EOM Pharmaceutical Holdings Inc (IMUC)
0.1840
+0.03
(+18.68%)
USD |
OTCM |
May 03, 16:00
EOM Pharmaceutical Holdings Total Assets (Quarterly): 3.829M for June 30, 2018
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2018 | 3.829M |
| March 31, 2018 | 5.165M |
| December 31, 2017 | 7.009M |
| September 30, 2017 | 6.776M |
| June 30, 2017 | 4.810M |
| March 31, 2017 | 10.51M |
| December 31, 2016 | 16.89M |
| September 30, 2016 | 22.23M |
| June 30, 2016 | 19.27M |
| March 31, 2016 | 24.69M |
| December 31, 2015 | 30.08M |
| September 30, 2015 | 30.85M |
| June 30, 2015 | 33.16M |
| March 31, 2015 | 36.98M |
| December 31, 2014 | 25.18M |
| September 30, 2014 | 25.38M |
| June 30, 2014 | 27.14M |
| March 31, 2014 | 26.28M |
| December 31, 2013 | 28.94M |
| September 30, 2013 | 29.94M |
| June 30, 2013 | 26.18M |
| March 31, 2013 | 25.07M |
| December 31, 2012 | 27.02M |
| September 30, 2012 | 10.69M |
| June 30, 2012 | 12.06M |
| Date | Value |
|---|---|
| March 31, 2012 | 14.42M |
| December 31, 2011 | 7.151M |
| September 30, 2011 | 8.889M |
| June 30, 2011 | 10.24M |
| March 31, 2011 | 11.37M |
| December 31, 2010 | 5.365M |
| September 30, 2010 | 6.369M |
| June 30, 2010 | 7.877M |
| March 31, 2010 | 2.730M |
| December 31, 2009 | 1.473M |
| September 30, 2009 | 2.034M |
| June 30, 2009 | 2.487M |
| March 31, 2009 | 2.638M |
| December 31, 2008 | 3.128M |
| September 30, 2008 | 3.595M |
| June 30, 2008 | 4.078M |
| March 31, 2008 | 4.559M |
| December 31, 2007 | 5.070M |
| September 30, 2007 | 5.404M |
| June 30, 2007 | 5.518M |
| March 31, 2007 | 3.012M |
| December 31, 2006 | 1.070M |
| September 30, 2006 | 1.137M |
| June 30, 2006 | 1.261M |
| March 31, 2006 | 1.390M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.4019M |
| Shareholders Equity (Quarterly) | 3.427M |